References

  1. Samara- Boustani D, Bachelot A, Pinto G, Thibaud E, Polack M, Touraine Ph. Blocs enzymatiques précoces de la surrénale. EMC (Elsevier Masson SAS, Paris), Endocrinologie-Nutrition, 10-015-B-20, 2008. Google Scholar

  2. Bhango A, Wilson R, New MI, Ten S. Donorsplice mutation in the 11 beta-hydroxylase (CYP11B1) generesulting in sex reversal : a case report and review of the literature. J Pediatr Endocrinol Metab.2006;19(10):1267- 82. PubMed | Google Scholar

  3. Rosatti Júnior R, Silva de Souza H, Tosatti A. Congenital adrenal hyperplasia due to 11- hydroxylase deficiency. Arquivos Brasileiros de Cardiologia. 2005;85(6):421-4. PubMed | Google Scholar

  4. Nimkarn S, New MI. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab. 2008;19(3):96-9. PubMed | Google Scholar

  5. Atabek ME, Pirgon O, Sert A. Hypokalemic rhabdomyolysis in a child with 11-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2008;21(1):93-6. PubMed | Google Scholar

  6. White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A. A mutation in CYP11B1 (Arg-48----His) associated with steroid 11 beta-hydroxylase deficiency in jews of Moroccan origin. J Clin Invest. 1991 ; 87(5): 1664- 1667. PubMed | Google Scholar

  7. Soardi FC, Penachioni JY, Justo GZ, Bachega TA, Inácio M, Mendonça BB, de Castro M, de Mello MP. Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients. J Clin Endocrinol Metab. 2009;94(9):3481-5. PubMed | Google Scholar

  8. David M, Bretones P, Zhu M, Forest M, Morel Y, Nicolino M, Chatelain P. Hyperplasie congénitale des surrénales et puberté premature. Medecine Clinique endocrinologie & diabète, 5ème journée d'Endocrinologie Sexuelle Alfred Jost. mars 2007; 22-27. PubMed | Google Scholar

  9. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI. Treatment with Growth Hormone and Luteinizing Hormone Releasing Hormone Analog Improves Final Adult Height in Children with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2005; 90(6):3318-3325. PubMed | Google Scholar

  10. Bougnères P. Que proposé pour améliorer de taille de certains patients atteints de bloc de la 21- hydroxylase? Medecine Clinique endocrinologie & diabète, 5ème journée d'Endocrinologie Sexuelle Alfred Jost.2007; 14-17. Google Scholar

  11. New MI, International Workshop on Management of Puberty for Optimum Auxological Results. Factors determining final height in congenital adrenal hyperplasia. J Pediatr Endocrinol Metab.2001;14Suppl 2:933-7. PubMed | Google Scholar

  12. Hargitai G, Solyoma J, Battelinod T, Leble J, Pribilincova Z, Hauspieg R, Kovacsc J, Waldhauseri F, Frischi H. Growth Patterns and Final Height in Congenital Adrenal Hyperplasia due to Classical 21-Hydroxylase Deficiency. HormRes. 2001;55(4):161-171. PubMed | Google Scholar

  13. Chalmers LJ, Casas L, New MI, Blackett PR. Prolongation of growth by treatment of 11-hydroxylase deficiency with depot-leuprolide, growth hormone, and hydrocortisone. J Pediatr Endocrinol Metab. 2006;19(10):1251-5. PubMed | Google Scholar